[{"address1": "4870 Sadler Road", "address2": "Suite 300", "city": "Glen Allen", "state": "VA", "zip": "23060", "country": "United States", "phone": "804 487 8196", "website": "https://www.adial.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Cary John Claiborne MBA", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 728307, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Goodman", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 249713, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vinay  Shah A.C.A., M.B.A.", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John R. Martin J.D.", "title": "Chief Legal Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Andrew  Taubman", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brigette  Robertson M.D.", "age": 60, "title": "Acting Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Catherine  Fratila", "title": "Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.788, "open": 0.7604, "dayLow": 0.7215, "dayHigh": 0.7753, "regularMarketPreviousClose": 0.788, "regularMarketOpen": 0.7604, "regularMarketDayLow": 0.7215, "regularMarketDayHigh": 0.7753, "beta": 1.175, "forwardPE": -0.5238162, "volume": 83509, "regularMarketVolume": 83509, "averageVolume": 150567, "averageVolume10days": 81060, "averageDailyVolume10Day": 81060, "bid": 0.7007, "ask": 0.7828, "bidSize": 100, "askSize": 100, "marketCap": 4798966, "fiftyTwoWeekLow": 0.72, "fiftyTwoWeekHigh": 4.17, "fiftyDayAverage": 0.9952, "twoHundredDayAverage": 1.0972, "currency": "USD", "enterpriseValue": -456381, "floatShares": 5954237, "sharesOutstanding": 6474590, "sharesShort": 60591, "sharesShortPriorMonth": 22546, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0094, "heldPercentInsiders": 0.0178, "heldPercentInstitutions": 0.09725001, "shortRatio": 0.44, "shortPercentOfFloat": 0.0095, "impliedSharesOutstanding": 6474590, "bookValue": 0.918, "priceToBook": 0.8074074, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -13031098, "trailingEps": -2.94, "forwardEps": -1.33, "lastSplitFactor": "1:25", "lastSplitDate": 1691366400, "enterpriseToEbitda": 0.056, "52WeekChange": -0.2330097, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ADIL", "underlyingSymbol": "ADIL", "shortName": "Adial Pharmaceuticals, Inc", "longName": "Adial Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1532698200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a144d6a7-1775-3bb1-b1ca-599a0edca1eb", "messageBoardId": "finmb_112638788", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.7412, "targetHighPrice": 8.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.5, "targetMedianPrice": 7.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5204346, "totalCashPerShare": 0.812, "ebitda": -8127002, "quickRatio": 6.278, "currentRatio": 6.777, "returnOnAssets": -1.06047, "returnOnEquity": -3.16945, "freeCashflow": -3400635, "operatingCashflow": -6691040, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]